thalidomide has been researched along with Aneurysm, Arteriovenous in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide has shown its efficacy in the treatment of epistaxis in hereditary hemorrhagic telangiectasia (HHT) patients." | 3.79 | Pulmonary arteriovenous malformations etiologies in HHT patients and potential utility of thalidomide. ( El Hajjam, M; Lacombe, P; Lacout, A; Marcy, PY, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lacout, A | 1 |
| Marcy, PY | 1 |
| El Hajjam, M | 1 |
| Lacombe, P | 1 |
1 other study available for thalidomide and Aneurysm, Arteriovenous
| Article | Year |
|---|---|
Pulmonary arteriovenous malformations etiologies in HHT patients and potential utility of thalidomide.
Topics: Angiogenesis Inhibitors; Arteriovenous Fistula; Humans; Models, Biological; Neovascularization, Path | 2013 |